ATRA may also play a role in reducing tau hyperphosphorylation by suppressing cell cycle proteins as cyclin B1 which is involved in the phosphorylation of tau and aberrantly expressed in Alzheimer’s disease patients [7]. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.